Literature DB >> 19118052

Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumors.

Terence P F Gade1, Ian M Buchanan, Matthew W Motley, Yousef Mazaheri, William M Spees, Jason A Koutcher.   

Abstract

PURPOSE: Low-molecular weight (LMW) chemotherapeutics are believed to reach tumors through diffusion across capillary beds as well as membrane transporters. Unexpectedly, the delivery of these agents seems to be augmented by reductions in tumor interstitial fluid pressure, an effect typically associated with high-molecular weight molecules that reach tumors principally through convection. We investigated the hypothesis that improved intratumoral convection can alter tumor metabolism and enhance the delivery of a LMW chemotherapeutic agent to solid tumors. EXPERIMENTAL
DESIGN: For this purpose, we applied 31P/19F magnetic resonance spectroscopy (MRS) and magnetic resonance spectroscopic imaging (MRSI) to examine the influence of type I collagenase on tumor bioenergetics and the delivery of 5-fluorouracil (5FU) to HT29 human colorectal tumors grown s.c. in mice.
RESULTS: Collagenase effected a 34% reduction in tumor interstitial fluid pressure with an attendant disintegration of intratumoral collagen. Neither mice-administered collagenase nor controls receiving PBS showed changes in (31)phosphorus MRS-measured tumor bioenergetics; however, a time-dependent increase in the content of extracellular inorganic phosphate (Pi(e)) was observed in tumors of collagenase-treated animals. (31)Phosphorus MRSI showed that this increase underscored a more homogeneous distribution of Pi(e) in tumors of experimental mice. (19)Fluorine MRS showed that these changes were associated with a 50% increase in 5FU uptake in tumors of experimental versus control animals; however, this increase resulted in an increase in 5FU catabolites rather than fluoronucleotide intermediates that are required for subsequent cytotoxicity.
CONCLUSIONS: These data indicate that the modulation of convective flow within tumors can improve the delivery of (LMW) chemotherapeutics and show the potential role for noninvasive imaging of this process in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19118052      PMCID: PMC4217124          DOI: 10.1158/1078-0432.CCR-08-0611

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  65 in total

1.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

Review 2.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

3.  Lowering of tumoral interstitial fluid pressure by prostaglandin E(1) is paralleled by an increased uptake of (51)Cr-EDTA.

Authors:  K Rubin; M Sjöquist; A M Gustafsson; B Isaksson; G Salvessen; R K Reed
Journal:  Int J Cancer       Date:  2000-06-01       Impact factor: 7.396

4.  The effects of isoflurane and halothane on blood flow and 31P NMR spectra in murine RIF-1 tumors.

Authors:  M Zhao; L G Fortan; J L Evelhoch
Journal:  Magn Reson Med       Date:  1995-05       Impact factor: 4.668

5.  Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure.

Authors:  R A Zlotecki; Y Boucher; I Lee; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

6.  Shielded solenoidal probe for in vivo NMR studies of solid tumors.

Authors:  T C Ng; J D Glickson
Journal:  Magn Reson Med       Date:  1985-04       Impact factor: 4.668

7.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.

Authors:  Y Boucher; R K Jain
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

8.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

9.  Interstitial hypertension in superficial metastatic melanomas in humans.

Authors:  Y Boucher; J M Kirkwood; D Opacic; M Desantis; R K Jain
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

10.  Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells.

Authors:  A S Ojugo; P M McSheehy; M Stubbs; G Alder; C L Bashford; R J Maxwell; M O Leach; I R Judson; J R Griffiths
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more
  25 in total

1.  Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model.

Authors:  Sungheon Kim; Lindsey Decarlo; Gene Y Cho; Jens H Jensen; Daniel K Sodickson; Linda Moy; Silvia Formenti; Robert J Schneider; Judith D Goldberg; Eric E Sigmund
Journal:  NMR Biomed       Date:  2011-11-09       Impact factor: 4.044

Review 2.  MRI and MRS of intact perfused cancer cell metabolism, invasion, and stromal cell interactions.

Authors:  Marie-France Penet; Tariq Shah; Flonne Wildes; Balaji Krishnamachary; Santosh K Bharti; Jesus Pacheco-Torres; Dmitri Artemov; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2019-01-28       Impact factor: 4.044

3.  Phenomenological model of interstitial fluid pressure in a solid tumor.

Authors:  L J Liu; S L Brown; J R Ewing; M Schlesinger
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2011-08-15

Review 4.  In Vivo Molecular Electron Paramagnetic Resonance-Based Spectroscopy and Imaging of Tumor Microenvironment and Redox Using Functional Paramagnetic Probes.

Authors:  Valery V Khramtsov
Journal:  Antioxid Redox Signal       Date:  2017-12-20       Impact factor: 8.401

Review 5.  Stromal reengineering to treat pancreas cancer.

Authors:  Ingunn M Stromnes; Kathleen E DelGiorno; Philip D Greenberg; Sunil R Hingorani
Journal:  Carcinogenesis       Date:  2014-06-07       Impact factor: 4.944

6.  Stromal regulation of vessel stability by MMP14 and TGFbeta.

Authors:  Nor E Sounni; Kerstin Dehne; Leon van Kempen; Mikala Egeblad; Nesrine I Affara; Ileana Cuevas; Jane Wiesen; Simon Junankar; Lidiya Korets; Jake Lee; Jennifer Shen; Charlotte J Morrison; Christopher M Overall; Stephen M Krane; Zena Werb; Nancy Boudreau; Lisa M Coussens
Journal:  Dis Model Mech       Date:  2010-03-11       Impact factor: 5.758

7.  Separation of Solid Stress From Interstitial Fluid Pressure in Pancreas Cancer Correlates With Collagen Area Fraction.

Authors:  Michael D Nieskoski; Kayla Marra; Jason R Gunn; Stephen C Kanick; Marvin M Doyley; Tayyaba Hasan; Stephen P Pereira; B Stuart Trembly; Brian W Pogue
Journal:  J Biomech Eng       Date:  2017-06-01       Impact factor: 2.097

Review 8.  Dynamic interplay between the collagen scaffold and tumor evolution.

Authors:  Mikala Egeblad; Morten G Rasch; Valerie M Weaver
Journal:  Curr Opin Cell Biol       Date:  2010-09-06       Impact factor: 8.382

9.  In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment.

Authors:  Andrey A Bobko; Timothy D Eubank; Benoit Driesschaert; Valery V Khramtsov
Journal:  J Vis Exp       Date:  2018-03-16       Impact factor: 1.355

10.  Diffusion-weighted imaging with acquisition of three b-values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapy.

Authors:  Guido M Kukuk; Petra Mürtz; Frank Träber; Carsten Meyer; Jan Ullrich; Jürgen Gieseke; Hojjat Ahmadzadehfar; Samer Ezziddin; Hans H Schild; Winfried A Willinek
Journal:  Eur Radiol       Date:  2013-10-01       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.